We do like a nice, frothy biotech IPO market. But is it coming at the expense of stellar acquisitions of private biotechs? We miss the kin...

It's time for the IN VIVO Blog's Fifth Annual Deal of the Year! competition. This year we're once again presenting awards in th...

The economy may be going down the tubes (More rate cuts! JPMorgan is buying Bear Stearns for $2/share !) but it least we've got the brac...

Well there's something you don't see every day: some floor-storming at Newman Arena! Over the weekend with victories against Dartmou...